Heavily T2-weighted 3D-FLAIR improves the detection of cochlear lymph fluid signal abnormalities in patients with sudden sensorineural hearing loss

Magnetic Resonance in Medical Sciences

Volumn 15, Issue 2, 2016, Pages 203-211

  Naganawa, Shinji ^a   Kawai, Hisashi ^a   Taoka, Toshiaki ^a   Suzuki, Kojiro ^a   Iwano, Shingo ^a   Satake, Hiroko ^a   Sone, Michihiko ^a   Ikeda, Mitsuru ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Magnetic resonance imaging; Sudden deafness; Temporal bone disease

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; COCHLEA; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCEPTION DEAFNESS; PROCEDURES; SUDDEN DEAFNESS; THREE DIMENSIONAL IMAGING; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; COCHLEA; FEMALE; HEARING LOSS, SENSORINEURAL; HEARING LOSS, SUDDEN; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84976902074     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.mp.2015-0065     Document Type: Article

References (29)

1. Sugiura M, Naganawa S, Teranishi M, Nakashima T. Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging findings in patients with sudden sensorineural hearing loss. Laryngoscope 2006; 116:1451–1454.
2. Zhu H, Ou Y, Fu J, Zhang Y, Xiong H, Xu Y. A compari son of inner ear imaging features at different time points of sudden sensorineural hearing loss with three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging. Eur Arch Otorhinolaryngol 2015; 272:2659–2665.
3. Berrettini S, Seccia V, Fortunato S, et al. Analysis of the 3-dimensional fluid-attenuated inversion-recovery (3D-FLAIR) sequence in idiopathic sudden sensori neural hearing loss. JAMA Otolaryngol Head Neck Surg 2013; 139:456–464.
4. Lee HY, Jung SY, Park MS, Yeo SG, Lee SY, Lee SK. Feasibility of three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging as a prognostic factor in patients with sudden hearing loss. Eur Arch Otorhinolaryngol 2012; 269:1885–1891.
5. Ryu IS, Yoon TH, Ahn JH, et al. Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging in sudden sensorineural hearing loss: correlations with audiologic and vestibular testing. Otol Neurotol 2011; 32:1205–1209.
6. Tanigawa T, Tanaka H, Sato T, et al. 3D-FLAIR MRI findings in patients with low-tone sudden deafness. Acta Otolaryngol 2010; 130:1324–1328.
7. Yoshida T, Sugiura M, Naganawa S, Teranishi M, Nakata S, Nakashima T. Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging findings and prognosis in sudden sensorineural hearing loss. Laryngoscope 2008; 118:1433–1437.
8. Gao Z, Chi FL. The clinical value of three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging in patients with idiopathic sudden sensorineural hearing loss: a meta-analysis. Otol Neurotol 2014; 35:1730–1735.
9. Tanigawa T, Shibata R, Tanaka H, et al. Usefulness of three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging to detect inner-ear abnormalities in patients with sudden sensorineural hearing loss. J Laryngol Otol 2015; 129:11–15.
10. Naganawa S, Kawai H, Sone M, Nakashima T. Increased sensitivity to low concentration gadolinium contrast by optimized heavily T2-weighted 3D-FLAIR to visualize endolymphatic space. Magn Reson Med Sci 2010; 9:73–80.
11. Naganawa S, Yamazaki M, Kawai H, Sone M, Nakashima T. Contrast enhancement of the anterior eye segment and subarachnoid space: detection in the normal state by heavily T2-weighted 3D FLAIR. Magn Reson Med Sci 2011; 10:193–199.
12. Nakashima T, Naganawa S, Sugiura M, et al. Visualization of endolymphatic hydrops in patients with Ménière’s dis ease. Laryngoscope 2007; 117:415–420.
13. Tagaya M, Teranishi M, Naganawa S, et al. 3 Tesla magnetic resonance imaging obtained 4 hours after intra venous gadolinium injection in patients with sudden deafness. Acta Otolaryngol 2010; 130:665–669.
14. Naganawa S, Yamazaki M, Kawai H, et al. MR imaging of Ménière’s disease after combined intratympanic and intravenous injection of gadolinium using HYDROPS2. Magn Reson Med Sci 2014; 13:133–137.
15. Naganawa S, Suzuki K, Yamazaki M, Sakurai Y, Ikeda M. Time course for measuring endolymphatic size in healthy volunteers following intravenous administration of gadoteridol. Magn Reson Med Sci 2014; 13:73–80.
16. Naganawa S, Suzuki K, Yamazaki M, Sakurai Y. Serial scans in healthy volunteers following intravenous administration of gadoteridol: time course of contrast enhancement in various cranial fluid spaces. Magn Reson Med Sci 2014; 13:7–13.
17. Naganawa S, Suzuki K, Nakamichi R, et al. Semi-quantification of endolymphatic size on MR imaging after intravenous injection of single-dose gadodiamide: comparison between two types of processing strategies. Magn Reson Med Sci 2013; 12:261–269.
18. Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Visualization of endolymphatic hydrops in Ménière’s disease after single-dose intra venous gadolinium-based contrast medium: timing of optimal enhancement. Magn Reson Med Sci 2012; 11:43–51.
19. Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Imaging of endolymphatic and perilymphatic fluid after intravenous administration of single-dose gadodiamide. Magn Reson Med Sci 2012; 11:145–150.
20. Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Imaging of Ménière’s disease by subtraction of MR cisternography from positive perilymph image. Magn Reson Med Sci 2012; 11:303–309.
21. Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Visualization of endolymphatic hydrops in Ménière’s disease with single-dose intra venous gadolinium-based contrast media using heavily T(2)-weighted 3D-FLAIR. Magn Reson Med Sci 2010; 9:237–242.
22. Homann G, Vieth V, Weiss D, et al. Semi-quantitative vs. volumetric determination of endolymphatic space in Ménière’s disease using endolymphatic hydrops 3T-HR-MRI after intravenous gadolinium injection. PLoS One 2015; 10:e0120357.
23. Homann G, Fahrendorf D, Niederstadt T, et al. HR 3 Tesla MRI for the diagnosis of endolymphatic hydrops and differential diagnosis of inner ear tumors—demon strated by two cases with similar symptoms. Rofo 2014; 186:225–229.
24. Naganawa S, Suzuki K, Nakamichi R, et al. Semi-quantification of endolymphatic size on MR imaging after single-dose intravenous injection of gadodiamide: comparison between two types of processing strategies. Magn Reson Med Sci 2013; 12:261–269.
25. Sara SA, Teh BM, Friedland P. Bilateral sudden sensorineural hearing loss: review. J Laryngol Otol 2014; 128 Suppl 1:S8–S15.
26. Dietrich O, Raya JG, Reeder SB, Reiser MF, Schoenberg SO. Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging 2007; 26:375–385.
27. Lattanzi R, Grant AK, Polimeni JR, et al. Performance evaluation of a 32-element head array with respect to the ultimate intrinsic SNR. NMR Biomed 2010; 23:142–151.
28. Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Imaging of Ménière’s disease after intravenous administration of single-dose gadodiamide: utility of multiplication of MR cisternography and HYDROPS image. Magn Reson Med Sci 2013; 12:63–68.
29. Naganawa S, Koshikawa T, Fukatsu H, Ishigaki T, Fukuta T. MR cisternography of the cerebellopontine angle: comparison of three-dimensional fast asymmetrical spin-echo and three-dimensional constructive interference in the steady-state sequences. AJNR Am J Neuroradiol 2001; 22:1179–1185.